Autism Spectrum Disorder Trial, Recruiting NCT07638657 Sponsor: Gaia AG Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT07638657
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have previously been suspected of having Autism Spectrum Disorder (ASD) by a healthcare professional
  • Your ASD diagnosis (a specific type of autism) has been confirmed through a structured interview carried out as an online/video consultation
  • Your IQ has been measured at 80 or above
  • You are currently experiencing a raised level of psychological distress, based on a specific questionnaire score (confirm with trial site for exact details)
  • Your current treatment — whether that is medication, therapy, or no treatment — has remained unchanged for at least 30 days before joining
  • You have a sufficient understanding of the German language
  • You have basic computer or technology skills needed to use a digital (online) programme independently
  • You are willing to give your consent to take part in the trial

Who may not be able to join:

  • You are planning to make any changes to your treatment (such as medication or therapy) within the 3 months after joining the trial
  • You have been diagnosed with another serious mental health condition, such as a severe mood disorder, psychosis, a severe substance use problem, borderline personality disorder, or antisocial personality disorder
  • You are currently having thoughts of suicide or are considered at immediate risk of harming yourself
  • You are currently under a legal guardianship arrangement that covers your healthcare decisions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Isabel Dziobek, Prof. Dr., Humboldt-Universität zu Berlin

Phone: +49 40 3510520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Gaia AG
Registry
ClinicalTrials.gov
Start date
12 June 2026
Est. completion
1 March 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

21-item Depression, Anxiety, and Stress Scales (DASS-21) total score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov